Lung Transplant for COPD
Although uncommon, lung transplants are sometimes used in chronic obstructive pulmonary disease (COPD). During a lung transplant, you are given a lung from a donor who has recently died. A single-lung transplant (receiving one lung) is done more often than a double-lung transplant (receiving two lungs). Improvement in the ability to exercise is nearly as good in people who have a single-lung transplant as it is in those who have a double-lung transplant.
Lung transplant surgery has been found to help people with COPD for at least 3 to 4 years after surgery. A transplant can improve breathing and quality of life. But the long-term benefit of lung transplant for people with COPD is not yet known.
Criteria have not been firmly established for selecting people with COPD to have a lung transplant. Lung transplant for people with COPD may be considered for those who:
Other things to think about for lung transplant include the following:
If you are interested in lung transplants, you may be referred to a transplant center, where you will have extensive physical and psychological testing to see whether you are a good candidate for a lung transplant. The testing includes exercise tests, lung function tests, heart function tests, numerous blood tests, psychological profiles, and other specialized testing. In addition, you need to demonstrate mental stability and the commitment that is needed to follow up with the medical demands after the transplant.
If you become a candidate for a transplant, you are placed on a waiting list. Depending on where the transplant center is located, the wait for a lung transplant can be from 1 year to over 2 years.
eMedicineHealth Medical Reference from Healthwise
To learn more visit Healthwise.org
© 1995-2014 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Lung Disease/COPD Resources
- 10 Symptoms of a COPD Flare-Up
- Are You At Risk for COPD?
- 6 Health Tips During Lung Cancer Immunotherapy